Abivax Sa ADR (ABVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 65,810 | 81,536 | 94,343 | 52,782 | 49,725 |
| Operating Income | -65,810 | -81,536 | -94,344 | -52,782 | -49,725 |
| Interest Expense | 5,582 | 4,429 | 108,767 | 6,147 | 7,083 |
| Other Income | 14,932 | 1,707 | 23,851 | 3,970 | 1,636 |
| Pre-tax Income | -56,460 | -84,258 | -179,260 | -54,960 | -55,172 |
| Income Tax | 267 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -56,727 | -90,874 | -179,260 | -54,960 | -55,172 |
| Net Income | $-56,727 | $-90,874 | $-179,260 | $-54,960 | $-55,172 |
| EPS Basic Total Ops | -0.71 | -1.27 | -2.45 | -0.86 | -0.87 |
| EPS Basic Continuous Ops | -0.72 | -1.28 | -2.46 | -0.87 | -0.87 |
| EPS Diluted Total Ops | -0.71 | -1.27 | -2.45 | -0.86 | -0.87 |
| EPS Diluted Continuous Ops | -0.72 | -1.28 | -2.46 | -0.87 | -0.87 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -1.19 | -2.45 | -0.86 | -0.87 |
| EBITDA(a) | $-65,381 | $-81,254 | $-94,008 | $-52,475 | $-49,438 |